PTEN deficiency causes dyschondroplasia in mice by enhanced hypoxia-inducible factor 1α signaling and endoplasmic reticulum stress
Author:
Yang Guan1, Sun Qiang1, Teng Yan1, Li Fangfei1, Weng Tujun1, Yang Xiao1
Affiliation:
1. State Key Laboratory of Proteomics, Genetic Laboratory of Development and Diseases, Institute of Biotechnology, 20 Dongdajie, Beijing 100071,China.
Abstract
Chondrocytes within the growth plates acclimatize themselves to a variety of stresses that might otherwise disturb cell fate. The tumor suppressor PTEN(phosphatase and tensin homolog deleted from chromosome 10) has been implicated in the maintenance of cell homeostasis. However, the functions of PTEN in regulating chondrocytic adaptation to stresses remain largely unknown. In this study, we have created chondrocyte-specific Pten knockout mice (Ptenco/co;Col2a1-Cre) using the Cre-loxP system. Following AKT activation, Pten mutant mice exhibited dyschondroplasia resembling human enchondroma. Cartilaginous nodules originated from Pten mutant resting chondrocytes that suffered from impaired proliferation and differentiation, and this was coupled with enhanced endoplasmic reticulum (ER) stress. We further found that ER stress in Pten mutant chondrocytes only occurred under hypoxic stress,characterized by an upregulation of unfolded protein response-related genes as well as an engorged and fragmented ER in which collagens were trapped. An upregulation of hypoxia-inducible factor 1α (HIF1α) and downstream targets followed by ER stress induction was also observed in Ptenmutant growth plates and in cultured chondrocytes, suggesting that PI3K/AKT signaling modulates chondrocytic adaptation to hypoxic stress via regulation of the HIF1α pathway. These data demonstrate that PTEN function in chondrocytes is essential for their adaptation to stresses and for the inhibition of dyschondroplasia.
Publisher
The Company of Biologists
Subject
Developmental Biology,Molecular Biology
Reference58 articles.
1. Ayala, G., Liu, C., Nicosia, R., Horowitz, S. and Lackman,R. (2000). Microvasculature and VEGF expression in cartilaginous tumors. Hum. Pathol.31,341-346. 2. Backman, S. A., Stambolic, V., Suzuki, A., Haight, J., Elia, A.,Pretorius, J., Tsao, M. S., Shannon, P., Bolon, B., Ivy, G. O. et al.(2001). Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease. Nat. Genet.29,396-403. 3. Blancher, C., Moore, J. W., Robertson, N. and Harris, A. L.(2001). Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3′-kinase/Akt signaling pathway. Cancer Res.61,7349-7355. 4. Brien, E. W., Mirra, J. M. and Kerr, R. (1997). Benign and malignant cartilage tumors of bone and joint: their anatomic and theoretical basis with an emphasis on radiology, pathology and clinical biology. I. the intramedullary cartilage tumors. Skeletal Radiol.26,325-353. 5. Chow, L. M. and Baker, S. J. (2006). PTEN function in normal and neoplastic growth. Cancer Lett.241,184-196.
Cited by
51 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|